Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Aura Biosciences, Inc. | AURA | 7.1M | $50.41M |
Mirum Pharmaceuticals, Inc. | MIRM | 7.68M | $899.06M |
Arcutis Biotherapeutics, Inc. | ARQT | 9.87M | $258.91M |
Trevi Therapeutics, Inc. | TRVI | 9.94M | $185.37M |
Phathom Pharmaceuticals, Inc. | PHAT | 12.47M | $135.26M |
NewAmsterdam Pharma Company N.V. | NAMS | 18.09M | $613.03M |
Allogene Therapeutics, Inc. | ALLO | 22.45M | $46.69M |
Erasca, Inc. | ERAS | 24.98M | $457.55M |